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TREATMENT OF BENIGN PROSTATIC HYPER・TROPHY
WITH ALLYLESTRENOL （GESTANON＠）
Hiroyuki TAKEuGHI， Aki皿asa YAMAuGHI，：Fumio OwADA and Iwao FuK：uI
 From the 1）ePar彦膨η彦げ～Yrology， Schoolげルtedicine， Tok■Oル川開♂and 1）ental翫勿θ7吻，
  Allylestrenol （GestanQnop）， one of popularlY used gestagens to prevent abortion， is said to reduce
the’垂窒盾№煤fate weight’6f adUlt’ral’ts’sh6wing ho androgenic， anabolic or estrogenic effeets． These effects
fi11 tip the 6bnditioris’ as a remedy of benign prostatic hypertrophy in human．
 ．．．耳gりrty庶負V¢卑g．舞1！yユ嬢t口耳gl Was adrr｝i孕is重ered daily on 20 cases Qf中e early benign prostatic hyper－
trophy fo．r．3 mQ． nths as a pilQt study． Effects on subjective syrnptomsi （dysuria and nocturia） and
objectiv6価dings．iUro宜。～vlhe捻y．and size of the prostate）were f（）正lowcd up。 The f（）rlner improved
in 600／． of the cases wh ereas the latter ・in 500／o of them． Both of them improved in 5 cases （250／．），
either one of them improved in 12 cases （600／o）， and neither one of them improved in 3 cases （15e／，）．
Totally 850／， of the cases were relieved from subjective symptoms and／or objective findings． This
result was thQught to be ’窒≠狽???excellent as a conservative treatment of benign prostatic hypertrophy．
Follow－up studies are expected to be done．































Tab1e I． Effects on noc加【ria．
Frequency before No・of
  treatment ca＄es
Frequency after treatment


















8 4 3 1
7  1  5  2  1
3 2    1
1





















＊ One of 20 cases in who a urethro l ootheter was






























Table 2． Effects on dysuria．
Urination before No． of
 セreqfmen奮   coses
Urinafion after treatment
Nearly normal A iifHe dlsturbed Stronqly disturbed Refention
Neorly normol 3
All廿le dis管urbed     l
Strongly distufbed 5








































Effects on uroflowmetry （measured．
by maximum flow rate）．
MFR after tre（コtmen†No． of coses （Ole）
More than 20e／o increased （imprQved｝
Less than 2001e changed （unchanged）









一5．4cm 5．5－4．4cm 4．5“i5，4cm 55－6，4cm





Total ’ 20 t45 t 2
＊ Slze ln the max；murn dlameter．
Tab］e 4． Effect on conslstency of the prostate．
Cpnslstency before
 treatment co＄es





1   －
16   1
3   一
1    －
14    1
2   t
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訂正：Table 1 4一行，一2列に1がぬけている．
   またfootnoteのwhoはwhomの， in order thatはowing toの誤りですb
